State Street Corp Kala Pharmaceuticals, Inc. Transaction History

State Street Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$0.25 - $11.7 $36,859 - $1.73 Million	-147,436 Reduced 56.33%	114,308 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $288,966 - $1.26 Million	-963,221 Reduced 78.63%	261,744 $79,000
Q1 2022 May 16, 2022	BUY	$0.61 - $1.84 $66,291 - $199,960	108,674 Added 9.74%	1,224,965 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $5,339 - $12,612	4,603 Added 0.41%	1,116,291 $1.35 Million
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $758,212 - $1.57 Million	289,394 Added 35.19%	1,111,688 $2.91 Million
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $620,092 - $998,766	122,548 Added 17.51%	822,294 $4.36 Million
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $112,519 - $172,746	-18,032 Reduced 2.51%	699,746 $4.72 Million
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $144,289 - $201,959	-22,976 Reduced 3.1%	717,778 $4.87 Million
Q3 2020 Nov 10, 2020	SELL	$7.5 - $11.11 $12,300 - $18,220	-1,640 Reduced 0.22%	740,754 $5.56 Million
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $2.62 Million - $4.33 Million	313,980 Added 73.29%	742,394 $7.8 Million
Q1 2020 May 11, 2020	BUY	$3.83 - $8.79 $1.64 Million - $3.77 Million	428,414 New	428,414 $3.77 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.